Furthermore, the relative rates of tumor proliferation (PR) and inhibition (IR) were computed, further substantiating that the combination of QRHXF and anti-PD-1 therapy effectively suppressed tumor growth (Table 1). Here, PDCD1 is linked to neoplasm.